INSTITUTO DE DIAGNÓSTICO S.A. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,499 CLP | +2.27% |
|
+2.15% | +18.68% |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site
| Sales 2022 | 191B 207M | Sales 2023 | 219B 236M | Capitalization | 178B 192M |
|---|---|---|---|---|---|
| Net income 2022 | 13.05B 14.09M | Net income 2023 | 144M 156K | EV / Sales 2022 | 1.7 x |
| Net Debt 2022 | 98.63B 107M | Net Debt 2023 | 99.27B 107M | EV / Sales 2023 | 1.27 x |
| P/E ratio 2022 |
17.4
x | P/E ratio 2023 |
1,234
x | Employees | 3,080 |
| Yield 2022 |
1.73% | Yield 2023 |
-
| Free-Float | 65.01% |
More Fundamentals
* Assessed data
More news
| 1 day | +2.27% | ||
| 1 week | +2.15% | ||
| Current month | +1.84% | ||
| 1 month | +1.32% | ||
| 3 months | +12.95% | ||
| 6 months | +6.62% | ||
| Current year | +18.68% |
1 week
1 460.80
1 500.00
1 month
1 448.001 500.00
Current year
1 199.201 530.00
1 year
1 170.001 530.00
3 years
1 170.001 800.10
5 years
1 170.002 195.00
10 years
1 170.002 679.48
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | - | |
| Director of Finance/CFO | - | 06-02-19 | |
| Chief Tech/Sci/R&D Officer | - | 04-04-05 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | - | |
| Chairman | - | - | |
| Director/Board Member | 72 | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-10 | 1,499 | +2.27% | 97,292 |
| 24-05-09 | 1,466 | -0.12% | 27,771 |
| 24-05-08 | 1,467 | 0.00% | 0 |
| 24-05-07 | 1,467 | 0.00% | 928 |
| 24-05-06 | 1,467 | 0.00% | 1,749 |
End-of-day quote Santiago S.E., May 09, 2024
More quotes
Instituto de Diagnostico SA is a Chile-based company engaged in the healthcare sector. The Company manages and operates Clinica Indisa, a private clinic located in the Santiago Metropolitan Region, which provides such hospital and outpatient services, as internal medicine admission and surgery, intensive and intermediate care units, pediatrics and neonatology, post-surgery recuperation, clinical laboratories, blood donation, radiology, endocrinology, computerized tomography, magnetic resonance imaging (MRI), nuclear medicine, hemodialysis and other outpatient procedures and services that cover all areas of medicine. As of December 31, 2011, the Company owned such subsidiaries as Servicios Integrados de Salud Ltda, Servicios Complementarios de Salud Ltda, Inmobiliaria San Cristobal SA and Indisa Laboratorio Ltda.
Sell
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
1,499
CLP
Average target price
1,900
CLP
Spread / Average Target
+26.75%
| 1st Jan change | Capi. | |
|---|---|---|
| +18.68% | 229M | |
| -18.90% | 16.51B | |
| +4.50% | 12.53B | |
| +4.81% | 11.74B | |
| +2.43% | 10.06B | |
| -4.75% | 7.57B | |
| +21.11% | 7.22B | |
| +5.46% | 6.68B | |
| +45.72% | 4.54B | |
| -3.49% | 4.32B |
- Stock Market
- Equities
- INDISA Stock